AXSM

Axsome Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

7.8%

Short % Float

5.1d to cover · Moderate squeeze

74.6%

Inst % Float

10 holders · 2026-06-30

Blackrock Inc.

Top Holder

5.9% of float

43.5M sh

Public Float

14/100

Dilution Score

Low

30 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

14/100

LOW

Inst: 74.57% · Top: Blackrock Inc.

Biotech Analytics

Neuroscience

37.88

Squeeze risk: MODERATEBiotech Grade: D

Insider Buying0

Publications100

Dilution Risk14

Clinical Trials100

Short Interest30